Drug intelligence / Profile preview

rubidium-82 generator

Development stage
Approved
Lead developer
Bracco Diagnostics
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Rubidium-82 generators are accelerator-produced radionuclide generator systems that contain strontium-82 adsorbed on a solid column (typically hydrous stannic oxide) and are eluted with additive-free 0.9% sodium chloride to produce sterile rubidium Rb-82 chloride injection for intravenous use.[7][10][4] The parent strontium-82 decays to the short‑lived positron-emitting daughter rubidium-82 (half-life ~75 seconds), which behaves as a potassium analog, is rapidly taken up by viable myocardium via Na+/K+ ATPase–dependent ion exchange, and enables positron emission tomography (PET) myocardial perfusion imaging under rest or pharmacologic stress in adults with suspected or established coronary artery disease.[7][5][4] These generators are used as in‑house sources of Rb‑82 for cardiac PET, provide repeated elutions over a service life of roughly 4–6 weeks depending on initial Sr‑82 loading, and require dedicated infusion/elution systems and strict quality control to limit strontium-82/strontium-85 breakthrough and avoid excessive radiation exposure.[7][4][3]

Brand names
CardioGen-82CardioGen82CardioGen 82RUBY-FILL
Other names
rubidium Rb 82 generatorrubidium-82 radionuclide generatorrubidium82 radionuclide generatorrubidium 82 radionuclide generator82Sr/82Rb generator
02

Targets

ATP1A (Sodium/potassium-transporting ATPase)

Beyond the preview

Go deeper on rubidium-82 generator.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rubidium-82 generator.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call